Back to Report Store Home

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

  • Published: Oct-2011
  • Report Code: GBIHC143MR
  • Report Format: pdf

Description

GBI Research, the leading business intelligence provider, has released its latest research, “Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future” which provides insights into the global contraceptives market and market forecasts until 2017. The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts. The report provides an in-depth analysis of the contraceptives most commonly used, such as oral, topical and injectable contraceptives, intrauterine devices, condoms and vaginal rings. The report also examines usage patterns for oral, topical and injectable contraceptives treatment. It also includes insights into the contraceptives R&D product pipeline and explores the competitive landscape, including major companies in the contraceptives market. Finally, the report also includes analysis of mergers and acquisitions (M&A) and licensing agreements that have taken place in the global contraceptives market.

The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.

GBI Research analysis shows that revenues are projected to increase from $15.5 billion in 2010 to $19.2 in 2017 at a CAGR of 3.1%. Prescription and OTC contraceptives held an 82% and 18% market share, respectively, in 2010. The intrauterine devices market was valued at $1,370.4m in 2010 and revenues are projected to increase to $1,398.1m in 2017, at a CAGR of 0.3%. However, revenues are expected to decline in 2015 due to the patent expiry of Mirena and the availability of low cost hormonal intrauterine devices. Strategic consolidations through acquisition accounted for 31% of M&A deals.

Scope

  • The report analyzes the market characterization, pipeline analysis and key M&A trends for oral, topical and injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market.

  • The scope of this report includes:

  • Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan.

  • Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2002–2010, with forecasts to 2017.

  • Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and annual cost of usage.

  • Key drivers and restraints that have had a significant impact on the market.

  • The competitive landscape of the contraceptives market, which includes companies such as Bayer, Johnson & Johnson, Reckitt Benckiser, Church & Dwight and Merck.

  • Key M&A activities and licensing agreements that took place from 2005–2011 in the contraceptives market.

Reasons To Buy

  • The report will enhance your decision making capability. It will allow you to:

  • Align your product portfolio to markets with high growth potential.

  • Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.

  • Devise a more tailored country strategy through understanding of key drivers and barriers in the contraceptives market.

  • Develop key strategic initiatives by understanding the key focus areas of leading companies.

  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5817
Or click here to contact us
Secure Payments
Cards